TY - JOUR
T1 - Bioreactor design for perfusion-based, highly vascularized organ regeneration
AU - Bijonowski, Brent M.
AU - Miller, William M.
AU - Wertheim, Jason A.
N1 - Funding Information:
W.M.M. acknowledges support from the Northwestern University Clinical and Translational Sciences Institute (NUCATS) Engineering into Medicine Mini-Sabbatical Program funded by CTSA Award UL1RR025741. We acknowledge the support of the Zell Family Foundation , the Excellence in Academic Medicine Act through the Illinois Department of Healthcare and Family Services, Northwestern Memorial Foundation Dixon Translational Research Grants Initiative , the Chemistry of Life Processes Chairman's Innovation Award , and the American Association for the Study of Liver Diseases and the American Liver Foundation Liver Scholar Award to J.A.W.
PY - 2013/2
Y1 - 2013/2
N2 - The production of bioartificial or laboratory-grown organs is a growing field centered on developing replacement organs and tissues to restore body function and providing a potential solution to the shortage of donor organs for transplantation. With the entry of engineered planar tissues, such as bladder and trachea, into clinical studies, an increasing focus is being given to designing complex, three-dimensional solid organs. As tissues become larger, thicker and more complex, the vascular network becomes crucial for supplying nutrients and maintaining viability and growth of the neo-organ. Perfusion decellularization, the process of removing cells from an entire organ, leaves the matrix of the vascular network intact. Organ engineering requires a delicate process of decellularization, sterilization, reseeding with appropriate cells, and organ maturation and stimulation to ensure optimal development. The design of bioreactors to facilitate this sequence of events has been refined to the extent that some bioartificial organs grown in these systems have been transplanted into recipient animals with sustained, though limited, function. This review focuses on the state-of-art in bioreactor development for perfusion-based bioartificial organs and highlights specific design components in need of further refinement.
AB - The production of bioartificial or laboratory-grown organs is a growing field centered on developing replacement organs and tissues to restore body function and providing a potential solution to the shortage of donor organs for transplantation. With the entry of engineered planar tissues, such as bladder and trachea, into clinical studies, an increasing focus is being given to designing complex, three-dimensional solid organs. As tissues become larger, thicker and more complex, the vascular network becomes crucial for supplying nutrients and maintaining viability and growth of the neo-organ. Perfusion decellularization, the process of removing cells from an entire organ, leaves the matrix of the vascular network intact. Organ engineering requires a delicate process of decellularization, sterilization, reseeding with appropriate cells, and organ maturation and stimulation to ensure optimal development. The design of bioreactors to facilitate this sequence of events has been refined to the extent that some bioartificial organs grown in these systems have been transplanted into recipient animals with sustained, though limited, function. This review focuses on the state-of-art in bioreactor development for perfusion-based bioartificial organs and highlights specific design components in need of further refinement.
UR - http://www.scopus.com/inward/record.url?scp=84875265313&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875265313&partnerID=8YFLogxK
U2 - 10.1016/j.coche.2012.12.001
DO - 10.1016/j.coche.2012.12.001
M3 - Review article
AN - SCOPUS:84875265313
SN - 2211-3398
VL - 2
SP - 32
EP - 40
JO - Current Opinion in Chemical Engineering
JF - Current Opinion in Chemical Engineering
IS - 1
ER -